BioSenic S.A. (EBR:BIOS)
Belgium
· Delayed Price · Currency is EUR 0.0023
-0.0001 (-4.17%)
At close: Dec 5, 2025
BioSenic Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Other Revenue | -2.39 | 0.1 | 0.34 | 0.3 | 0.31 |
| Revenue | -2.39 | 0.1 | 0.34 | 0.3 | 0.31 |
| Revenue Growth (YoY) | - | -69.64% | 13.51% | -5.13% | - |
| Gross Profit | -2.39 | 0.1 | 0.34 | 0.3 | 0.31 |
| Selling, General & Admin | 1.88 | 2.77 | 3.65 | 1.55 | 0.57 |
| Research & Development | 0.6 | 2.31 | 3.93 | 1.03 | 0.62 |
| Other Operating Expenses | 0.23 | 0.23 | -0.21 | 0.03 | - |
| Operating Expenses | 2.75 | 5.31 | 23.47 | 2.61 | 1.19 |
| Operating Income | -5.14 | -5.21 | -23.13 | -2.32 | -0.88 |
| Interest Expense | -0.97 | -1.68 | -1.49 | -0.24 | -0.11 |
| Interest & Investment Income | 0.06 | 0.06 | 0.06 | 0 | - |
| Currency Exchange Gain (Loss) | 0 | 0 | 0 | -0 | - |
| Other Non Operating Income (Expenses) | 0.11 | 0.12 | -4.47 | -0.5 | - |
| Pretax Income | -5.94 | -6.71 | -29.03 | -3.05 | -0.98 |
| Income Tax Expense | - | - | -0.01 | - | - |
| Earnings From Continuing Operations | -5.94 | -6.71 | -29.02 | -3.05 | -0.98 |
| Minority Interest in Earnings | 1.94 | 1.94 | 0.24 | 1.01 | - |
| Net Income | -4 | -4.77 | -28.78 | -2.04 | -0.98 |
| Net Income to Common | -4 | -4.77 | -28.78 | -2.04 | -0.98 |
| Shares Outstanding (Basic) | 432 | 231 | 137 | 120 | 0 |
| Shares Outstanding (Diluted) | 432 | 231 | 137 | 120 | 0 |
| Shares Change (YoY) | 150.43% | 68.94% | 13.98% | 181686.84% | - |
| EPS (Basic) | -0.01 | -0.02 | -0.21 | -0.02 | -14.89 |
| EPS (Diluted) | -0.01 | -0.02 | -0.21 | -0.02 | -14.89 |
| Free Cash Flow | -1.82 | -2.22 | -3.47 | -1.92 | -1.07 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.03 | -0.02 | -16.15 |
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | - | -5103.92% | -6884.82% | -783.11% | -281.09% |
| Profit Margin | - | -4674.51% | -8564.88% | -689.53% | -315.38% |
| Free Cash Flow Margin | - | -2177.45% | -1032.74% | -646.96% | -341.99% |
| EBITDA | -4.81 | -4.92 | -22.79 | -2.3 | -0.86 |
| EBITDA Margin | - | - | - | - | -276.92% |
| D&A For EBITDA | 0.33 | 0.29 | 0.34 | 0.02 | 0.01 |
| EBIT | -5.14 | -5.21 | -23.13 | -2.32 | -0.88 |
| EBIT Margin | - | - | - | - | -281.09% |
| Revenue as Reported | 0.58 | 3.07 | 0.54 | 0.27 | 0.31 |
Source: S&P Capital IQ. Standard template. Financial Sources.